Quartuccio, Luca
 Distribuzione geografica
Continente #
AS - Asia 700
NA - Nord America 480
EU - Europa 291
SA - Sud America 223
AF - Africa 26
OC - Oceania 2
Totale 1.722
Nazione #
US - Stati Uniti d'America 446
SG - Singapore 273
BR - Brasile 184
CN - Cina 141
VN - Vietnam 82
HK - Hong Kong 79
IT - Italia 68
BD - Bangladesh 38
RU - Federazione Russa 38
DE - Germania 35
FI - Finlandia 27
TR - Turchia 24
GB - Regno Unito 22
FR - Francia 21
AR - Argentina 15
MX - Messico 15
PL - Polonia 15
JP - Giappone 12
NL - Olanda 12
CA - Canada 11
ZA - Sudafrica 10
IN - India 9
AT - Austria 8
EC - Ecuador 8
ES - Italia 7
CO - Colombia 6
IE - Irlanda 6
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
UA - Ucraina 6
EG - Egitto 5
UZ - Uzbekistan 5
ID - Indonesia 4
PE - Perù 4
SE - Svezia 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
JO - Giordania 3
PT - Portogallo 3
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
HN - Honduras 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 1.722
Città #
Singapore 114
Hong Kong 79
Ashburn 49
Beijing 38
The Dalles 35
Ho Chi Minh City 33
San Jose 28
Helsinki 23
Los Angeles 22
Istanbul 20
New York 20
Hanoi 18
Lauterbourg 18
Council Bluffs 17
São Paulo 17
Warsaw 14
Buffalo 12
Milan 12
Tokyo 12
Moscow 11
Munich 11
Redondo Beach 11
Romola 11
Shanghai 11
Nuremberg 9
Curitiba 8
Dallas 8
Johannesburg 8
Biên Hòa 7
Brooklyn 7
Rome 7
San Francisco 7
Chicago 6
Dublin 6
Phoenix 6
Amsterdam 5
Mexico City 5
Poplar 5
Rio de Janeiro 5
Tashkent 5
Atlanta 4
Belo Horizonte 4
Brasília 4
Cairo 4
Charlotte 4
Da Nang 4
Denver 4
Dhaka 4
Faisalabad 4
Haiphong 4
Lappeenranta 4
Pescara 4
Porto Alegre 4
Salt Lake City 4
Santa Clara 4
Stockholm 4
Amman 3
Baghdad 3
Baku 3
Brno 3
Bắc Ninh 3
Caxias do Sul 3
Chennai 3
Guangzhou 3
Hangzhou 3
João Pessoa 3
Montreal 3
Orlando 3
Quito 3
Sorocaba 3
Vienna 3
Zhengzhou 3
Betim 2
Birmingham 2
Brussels 2
Buenos Aires 2
Chieti 2
City of London 2
Cleveland 2
Dalian 2
Don Torcuato 2
Falkenstein 2
Fortaleza 2
Frankfurt am Main 2
Imbituba 2
Jacksonville 2
Jieyang 2
Lima 2
London 2
Madrid 2
Magé 2
Manchester 2
Miami 2
Naples 2
Newark 2
Nova Iguaçu 2
Osasco 2
Paris 2
Portoviejo 2
Providence 2
Totale 908
Nome #
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 117
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 94
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 92
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 86
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 85
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 83
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 81
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis 79
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 74
Breakthrough SARS‑CoV‑2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID‑19 Vaccination in Autoimmune Disease (COVAD) study 73
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 72
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 72
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 70
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 70
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 69
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 69
COVAD survey 2 long-term outcomes: unmet need and protocol 69
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment 68
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 66
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study 60
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 60
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment 59
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 58
Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD Study 21
Totale 1.747
Categoria #
all - tutte 8.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 13 0 1 2 0 3 5
2023/2024133 3 5 11 12 2 14 4 1 29 3 5 44
2024/2025487 7 20 17 45 24 48 73 67 41 35 84 26
2025/20261.075 85 199 94 144 137 51 101 54 42 86 51 31
2026/202728 28 0 0 0 0 0 0 0 0 0 0 0
Totale 1.747